Pinnacle Holdings’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,292
Closed -$13.7K 233
2024
Q1
$13.7K Hold
1,292
0.01% 217
2023
Q4
$15.5K Hold
1,292
0.01% 210
2023
Q3
$9.04K Hold
1,292
﹤0.01% 198
2023
Q2
$11K Hold
1,292
﹤0.01% 198
2023
Q1
$11.8K Hold
1,292
0.01% 227
2022
Q4
$14.7K Sell
1,292
-139
-10% -$2.06K 0.01% 201
2022
Q3
$24.4K Sell
1,431
-128
-8% -$2.75K 0.01% 197
2022
Q2
$33.5K Sell
1,559
-37
-2% -$1.03K 0.02% 194
2022
Q1
$59K Hold
1,596
0.02% 187
2021
Q4
$72.6K Hold
1,596
0.03% 192
2021
Q3
$101K Buy
+1,596
New +$122K 0.04% 174
2021
Q2
Sell
-250
Closed -$17K 204
2021
Q1
$17K Hold
250
0.01% 199
2020
Q4
$18.1K Hold
250
0.01% 201
2020
Q3
$9.48K Buy
+250
New +$8.44K 0.01% 207

Other funds holding CDNA

Pinnacle Holdings's CDNA Position: Q2 2024 in Review

Pinnacle Holdings sold out of CareDx (CDNA) in Q2 2024, closing a stake of 1,292 shares — an estimated $13.7K sold.

Pinnacle Holdings first reported a position in CDNA in Q3 2020 and held it in 14 quarters. The position peaked at $101K in Q3 2021. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • Pinnacle Holdings reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • Pinnacle Holdings sold 1,292 CareDx shares in Q2 2024, an estimated $13.7K.
  • Pinnacle Holdings first reported a position in CareDx in Q3 2020 and held it in 14 quarters.
  • Pinnacle Holdings's CareDx position peaked at $101K in Q3 2021.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on Pinnacle Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.